Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals shares soared 24.05 percent on volume of 1.34 million shares traded Tuesday to close at $8.46. The company announced that the FDA has approved Amitiza for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on